March 17, 2023

Primary Resistance to Larotrectinib in a Patient with Squamous Non-Small Cell Lung Cancer with Subclonal NTRK1 Fusion: Case Report

  • Mary C. Boulanger,
  • Jennifer S. Temel,
  • Mari Mino-Kenudson,
  • Lauren L. Ritterhouse,
  • Ibiayi Dagogo-Jack
Published online: March 17, 2023
100501

March 15, 2023

Exon20-mutated NSCLC: Extending the dataset to allow the recognition of potential causes.

  • Nico van Zandwijk,
  • Christopher I. Amos,
  • Oluf Dimitri Røe,
  • Glen Reid,
  • Sonja Klebe
Published online: March 15, 2023
100500

March 10, 2023

Asian Subgroup Analysis of the Randomized Phase 3 CROWN Study of First-Line Lorlatinib vs Crizotinib in Advanced ALK-Positive Non-Small Cell Lung Cancer

  • Qing Zhou,
  • Ross A. Soo,
  • Gee-Chen Chang,
  • ...
  • Tony Mok,
  • Hye Ryun Kim,
  • Yi-Long Wu
Published online: March 10, 2023
100499

High levels of CD47 expression in thymic epithelial tumors

  • Thomas Yang Sun,
  • Brandon Nguyen,
  • Simon B. Chen,
  • ...
  • Joel W. Neal,
  • Heather Wakelee,
  • Jonathan W. Riess
Published online: March 10, 2023
100498

Biopsy Method and Needle Size on Success of Next-Generation Sequencing in Non-Small Cell Lung Cancer: A Brief Report

  • Raymond Diep,
  • Madeline MacDonald,
  • Ryan Cooper,
  • ...
  • Angeline Uy,
  • Nicholas Cowgill,
  • Jorge Nieva
Published online: March 10, 2023
100497

Racial, Ethnic, and Socioeconomic Characteristics Independently Predict for Cachexia Risk and Associated Survival Outcomes in Stage IV Non-Small Cell Lung Cancer: A Brief Report

  • Santiago Olaechea,
  • Alison Liu,
  • Brandon Sarver,
  • ...
  • Kayvon Yazdanbakhsh,
  • Rodney Infante,
  • Puneeth Iyengar
Published online: March 10, 2023
100496

March 7, 2023

PD-1 Inhibitor-Mediated Peripheral Neuropathy

  • Xia Zhang,
  • Ming Gao,
  • Binbin Sun,
  • ...
  • Xuejiao Yang,
  • Yanfang Ju,
  • Junxun Ma
Published online: March 07, 2023
100495

Thyroid transcription factor 1 expression related to clinical outcomes of combined chemoimmunotherapy in patients with advanced lung adenocarcinoma: a prospective observational study1

  • Yuki Katayama,
  • Tadaaki Yamada,
  • Kenji Morimoto,
  • ...
  • Shinsaku Tokuda,
  • Young Hak Kim,
  • Koichi Takayama
Published online: March 07, 2023
100494

February 28, 2023

Brief Report: Prognostic relevance of 3q amplification in squamous cell carcinoma of the lung

  • Fawzi Abu Rous,
  • Pin Li,
  • Shannon Carskadon,
  • ...
  • Hassan Abushukair,
  • Shirish Gadgeel,
  • Nallasivam Palanisamy
Published online: February 28, 2023
100486

February 24, 2023

LOREALAUS: LOrlatinib REAL world AUStralian experience in advanced anaplastic lymphoma kinase rearranged non-small cell lung cancer

  • Marliese Alexander,
  • Joe Wei,
  • Sagun Parakh,
  • ...
  • Nick Pavlakis,
  • Benjamin J Solomon,
  • Malinda Itchins
Published online: February 24, 2023
100490

MR-Guided SBRT/Hypofractionated RT for Metastatic and Primary Central and Ultracentral Lung Lesions

  • Maria L. Sandoval,
  • Austin J. Sim,
  • John M. Bryant,
  • ...
  • Vladimir Feygelman,
  • Kujtim Latifi,
  • Stephen A. Rosenberg
Published online: February 24, 2023
100488

Economic Burden of Recurrence Among Resected Medicare Patients With Early Stage Non-Small Cell Lung Cancer

  • Jay M. Lee,
  • Rongrong Wang,
  • Ann Johnson,
  • Sarika Ogale,
  • Matthew Kent,
  • Janet S. Lee
Published online: February 24, 2023
100487

February 23, 2023

Real-world Comparative Effectiveness of First-Line Alectinib Versus Crizotinib in Patients with Advanced ALK-Positive NSCLC with or without Baseline Central Nervous System Metastases

  • Qing Zhang,
  • Jessica J. Lin,
  • Navdeep Pal,
  • ...
  • Nino Kurtsikidze,
  • Venice Archer,
  • Matthew G. Krebs
Published online: February 23, 2023
100483

Impact of Performance Status on Survival Outcomes and Health Care Utilization in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors

  • Daniel E. Meyers,
  • Meghann Pasternak,
  • Samantha Dolter,
  • ...
  • Winson Y. Cheung,
  • Don G. Morris,
  • Aliyah Pabani
Published online: February 23, 2023
100482

Trastuzumab-emtansine and osimertinib (TRAEMOS) combination therapy to target HER2 bypass track resistance in EGFR mutation positive NSCLC

  • M. Jebbink,
  • A.J. de Langen,
  • K. Monkhorst,
  • ...
  • M.S. Paats,
  • A.C. Dingemans,
  • E.F. Smit
Published online: February 23, 2023
100481

February 10, 2023

Clinical characteristics and pharmacokinetics change of long-term responders to anti-PD-1 inhibitor among patients with advanced non-small-cell lung cancer

  • Hitomi Jo,
  • Tatsuya Yoshida,
  • Shigehiro Yagishita,
  • ...
  • Noriko Motoi,
  • Akinobu Hamada,
  • Yuichiro Ohe
Published online: February 10, 2023
100474

February 2, 2023

First-line lorlatinib versus crizotinib in ALK-positive non-small cell lung cancer: Japanese subgroup analysis of CROWN

  • Hidetoshi Hayashi,
  • Shunsuke Teraoka,
  • Yasushi Goto,
  • ...
  • Masayuki Okura,
  • Gerson Peltz,
  • Terufumi Kato
Published online: February 02, 2023
100471
Advertisement